Plasma Quantification of Cathepsin D and FAS in Non-Small Cell Lung Cancer
- Measure plasma cathepsin D levels in patients with non-small cell lung cancer and in
healthy volunteers using mass spectometry.
- Measure fatty acid synthase levels in these patients and healthy volunteers using mass
OUTLINE: Blood samples are collected from patients and healthy volunteers to measure the
levels of cathepsin D and fatty acid synthase by proteomic profiling and mass spectrometry.
Observational Model: Cohort, Time Perspective: Prospective
Levels of cathepsin D
Measure plasma CD levels in patients with non-small cell lung cancer and non-smoker healthy controls using mass spectrometry.
At Routine Follow-Up
Robert A. Kratzke, MD
Masonic Cancer Center, University of Minnesota
United States: Food and Drug Administration
|Masonic Cancer Center at University of Minnesota||Minneapolis, Minnesota 55455|